{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:28:02Z","timestamp":1754195282450},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,12]]},"DOI":"10.7759\/cureus.21176","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:00:25Z","timestamp":1642017625000},"source":"Crossref","is-referenced-by-count":13,"title":["Eosinophilic Granulomatosis With Polyangiitis Diagnosed in an Elderly Female After the Second Dose of mRNA Vaccine Against COVID-19"],"prefix":"10.7759","author":[{"given":"Hanan","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayad","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Meysami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020, 383:2603-15. 10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden LR","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al.. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021, 384:403-16. 10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff J","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, et al.. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021, 384:2187-201. 10.1056\/NEJMoa2101544","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1573397113666170517155443","article-title":"Vasculitis following influenza vaccination: a review of the literature","volume":"13","author":"Watanabe T","year":"2017","unstructured":"Watanabe T. Vasculitis following influenza vaccination: a review of the literature. Curr Rheumatol Rev. 2017, 13:188-96. 10.2174\/1573397113666170517155443","journal-title":"Curr Rheumatol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab273","article-title":"Eosinophilic granulomatosis with polyangiitis after COVID-19 vaccination","volume":"114","author":"Chan-Chung C","year":"2021","unstructured":"Chan-Chung C, Ong CS, Chan LL, Tan EK. Eosinophilic granulomatosis with polyangiitis after COVID-19 vaccination. QJM. 2021, 114:807-9. 10.1093\/qjmed\/hcab273","journal-title":"QJM"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05691-x","article-title":"COVID-19 and the clinical course of rheumatic manifestations","volume":"40","author":"Ahmed S","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021, 40:2611-9. 10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30420-3","article-title":"COVID-19 vasculitis and novel vasculitis mimics","volume":"3","author":"McGonagle D","year":"2021","unstructured":"McGonagle D, Bridgewood C, Ramanan AV, Meaney JF, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021, 3:e224-33. 10.1016\/S2665-9913(20)30420-3","journal-title":"Lancet Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni L","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, et al.. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020, 395:1771-8. 10.1016\/S0140-6736(20)31103-X","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18985","article-title":"A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine","volume":"13","author":"Malayala SV","year":"2021","unstructured":"Malayala SV, Papudesi BN, Sharma R, Vusqa UT, Raza A. A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus. 2021, 13:e18985. 10.7759\/cureus.18985","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10785-2","article-title":"Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. [PREPRINT]","author":"Khan E","year":"2021","unstructured":"Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. [PREPRINT]. J Neurol. 2021, 10.1007\/s00415-021-10785-2","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18291","article-title":"Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine","volume":"13","author":"Dalwadi V","year":"2021","unstructured":"Dalwadi V, Hancock D, Ballout AA, Geraci A. Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus. 2021, 13:e18291. 10.7759\/cureus.18291","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19616","article-title":"De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19","volume":"13","author":"Feghali EJ","year":"2021","unstructured":"Feghali EJ, Zafar M, Abid S, Santoriello D, Mehta S. De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19. Cureus. 2021, 13:e19616. 10.7759\/cureus.19616","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79409-eosinophilic-granulomatosis-with-polyangiitis-diagnosed-in-an-elderly-female-after-the-second-dose-of-mrna-vaccine-against-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:46Z","timestamp":1707507706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79409-eosinophilic-granulomatosis-with-polyangiitis-diagnosed-in-an-elderly-female-after-the-second-dose-of-mrna-vaccine-against-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.21176","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}